Rapid antigens testing is just as effective in preventing COVID-19 outbreaks as polymerase chain reaction, or PCR, tests when used as part of a regular screening program, according to the National Institutes of Health. Source: McKnight's Long-Term Care News

A small study funded by the US National Institutes of Health (NIS) has found that Covid-19 lateral flow tests (LFTs) can be as effective in detecting SARS-CoV-2 infection as polymerase chain reaction (PCR) tests when used for serial screening conducted every three days. Source: Medical Device Network.

A small study funded by NIH has found that COVID-19 antigen testing and PCR tests are equally effective in detecting SARS-CoV-2 infection when used for serial screening conducted every three days. The results are good news for antigen test makers such as Abbott, Becton Dickinson and Quidel. Source: Medtechdive

The editors of MIT Technology Review introduce this year's 35 brilliant young entrepreneurs, inventors, visionaries, humanitarians and pioneers who are working to make the world a better place. Source: MIT Technology Review

Amid the continued deluge of emergency use authorizations from the FDA, rapid antigen tests for COVID-19 are more widely available and easily accessible than ever. Source: FierceBiotech

In a study that compares rapid antigen and laboratory PCR approaches for COVID-19 serial screening, researchers affiliated with the NIH RADx initiative reported results from 43 people infected with the virus.

A change of instructions in a computer program directs the computer to execute a different command. Similarly, synthetic biologists are learning the rules for how to direct the activities of human cells.

NIH researchers report that the prevalence of COVID-19 in the United States during spring and summer of 2020 far exceeded the known number of cases. For every diagnosed COVID-19 case in this time frame, the researchers estimate that there were 4.8 undiagnosed cases, representing an additional 16.8 million cases by July alone.

This study investigates how the nucleocapsid protein, or N protein, of the SARS-CoV-2 virus packages the viral genome.